A carregar...

Targeting ALK in neuroblastoma—preclinical and clinical advancements

Despite improvements in cancer therapies in the past 50 years, neuroblastoma remains a devastating clinical problem and a leading cause of childhood cancer deaths. Advances in treatments for children with high-risk neuroblastoma have, until recently, involved addition of cytotoxic therapy to dose-in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Carpenter, Erica L., Mossé, Yael P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3683972/
https://ncbi.nlm.nih.gov/pubmed/22585002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2012.72
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!